Cancer Gene Therapy

Papers
(The H4-Index of Cancer Gene Therapy is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms447
Key chemokines direct migration of immune cells in solid tumors193
Cancer-associated fibroblasts: overview, progress, challenges, and directions160
Interplay between MTOR and GPX4 signaling modulates autophagy-dependent ferroptotic cancer cell death132
METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway98
The KRAS-G12C inhibitor: activity and resistance66
ESCRT-III-mediated membrane repair in cell death and tumor resistance55
LOX-1 and cancer: an indissoluble liaison53
Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study52
HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer51
Nanomedicine-based cancer immunotherapy: recent trends and future perspectives46
Roles of miRNA dysregulation in the pathogenesis of multiple myeloma40
Hsa_circRNA_102002 facilitates metastasis of papillary thyroid cancer through regulating miR-488-3p/HAS2 axis39
Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy39
Expression pattern of m6A regulators is significantly correlated with malignancy and antitumor immune response of breast cancer39
Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance39
CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse model37
Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy36
Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma34
TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential33
Oncolytic adenoviruses synergistically enhance anti-PD-L1 and anti-CTLA-4 immunotherapy by modulating the tumour microenvironment in a 4T1 orthotopic mouse model33
Extracellular vesicles-encapsulated microRNA-10a-5p shed from cancer-associated fibroblast facilitates cervical squamous cell carcinoma cell angiogenesis and tumorigenicity via Hedgehog signaling path31
LncRNA LINC01857 promotes cell growth and diminishes apoptosis via PI3K/mTOR pathway and EMT process by regulating miR-141-3p/MAP4K4 axis in diffuse large B-cell lymphoma29
The V-ATPases in cancer and cell death29
Oncolytic virus promotes tumor-reactive infiltrating lymphocytes for adoptive cell therapy29
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD4028
GINS2 promotes EMT in pancreatic cancer via specifically stimulating ERK/MAPK signaling28
Protein post-translational modifications in the regulation of cancer hallmarks27
Cytokine-enhanced cytolytic activity of exosomes from NK Cells27
0.073736906051636